The Respiratory "overlap Syndrome": Efficacy and Usefulness of the Combined Double Bronchodilation

Flaminio Mormile, Leonello Fuso, Albino Petrone, Filippo Luca Fimognari, Michela Quartieri, Ludovico Petrone, Francesco Romano

Research output: Contribution to journalArticle


The coexistence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea syndrome in a single patient is known as "overlap syndrome," and worsens the prognosis of the affected subjects. A marked bronchodilation may be useful for the treatment of this condition. In fact, as stated in the GOLD 2017 guidelines, the combination of indacaterol/glycopyrronium may exert positive synergistic effects on smooth muscle cell and airway resistance, with a more pronounced efficiency in reducing lung hyperinflation. Noteworthy, inhaled bronchodilators favorably alter the dynamically determined components of resting lung hyperinflation and help deflate the overinflated lungs. This is particularly important in order to improve dyspnea, exercise performance, and night saturation, especially when combined with continuous positive airway pressure ventilation, as reported in our case series. We report 3 cases of patients with COPD in a stable clinical condition, referred to the Department of Respiratory Pathophysiology at the "Mariano Santo" Hospital in Cosenza, due to possible symptoms suggestive of obstructive sleep apnea, and who were successfully treated with indacaterol/glycopyrronium at a fixed dose.
Original languageEnglish
Pages (from-to)15-18
Number of pages4
Publication statusPublished - 2018


  • Chronic obstructive pulmonary disease
  • GOLD stage
  • Glycopyrronium
  • Indacaterol
  • Obstructive sleep apnea syndrome
  • Overlap syndrome


Dive into the research topics of 'The Respiratory "overlap Syndrome": Efficacy and Usefulness of the Combined Double Bronchodilation'. Together they form a unique fingerprint.

Cite this